A photo of Anne Lucky.

Medical Director, Epidermolysis Bullosa Center

Volunteer Professor of Dermatology and Pediatrics, UC Department of Pediatrics



Board Certified

Best Doctors logo

About Me


As a pediatric dermatologist, I have a special interest in epidermolysis bullosa (EB), and I also care for patients with other genetic disorders and those with difficult acne.

I wanted to be a pediatrician for as long as I can remember. Before I became a pediatric dermatologist, I practiced in general pediatrics, genetics and pediatric endocrinology. I was drawn to caring for children with EB because they are underserved, and many of their needs are complex.

At Cincinnati Children’s interdisciplinary Epidermolysis Bullosa Center, our team offers comprehensive care for all aspects of EB. We are happy to work with patients and their families to give them the best possible diagnoses and treatments.

My background allows me to evaluate and care for the whole patient with the help from my colleagues at Cincinnati Children’s. I believe each patient and family deserves my full attention. It’s vital to listen to patients and know them as people, not just to understand their medical issues. I also know the limits of my knowledge and consult with my colleagues in other specialties.

I have been honored to receive several awards for my clinical practice and service over the years. These recognitions have come from national societies such as the American Academy of Pediatrics, the Society for Pediatric Dermatology and the Dermatology Foundation.

In my research, my colleagues and I are doing clinical trials of new medications for EB and looking into gene therapy to help with wound healing.

In my spare time, my husband and I love to hike and travel. Visiting with my grandchildren is one of my greatest pleasures.

Clinical Interests

All aspects of pediatric dermatology, especially acne

Academic Affiliation

Volunteer Professor of Dermatology and Pediatrics, UC Department of Pediatrics


Dermatology, Hemangioma and Vascular Malformations, Epidermolysis Bullosa EB

My Locations

My Education

BA: Pembroke College in Brown University, Providence, RI, 1966.

MD: Yale University School of Medicine, New Haven, CT, 1970.

Residency: Children's Hospital Medical Center, Boston, MA, 1973; Yale University School of Medicine, New Haven, CT, 1981.

Fellowship: Human Genetics and Pediatrics, Yale University School of Medicine, New Haven, CT, 1974; Clinical Associate (Endocrinology), Reproduction Research Branch of the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Md., 1976.

Certification: Pediatrics, 1975; Pediatric Endocrinology, 1978; Dermatology, 1981.

My Publications

Collagen VII Expression is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes. Supp, DM; Hahn, JM; Combs, KA; McFarland, KL; Schwentker, A; Boissy, RE; Boyce, ST; Powell, HM; Lucky, AW. Cell Transplantation. 2019; 28:1242-1256.

Persistent linear pruritic papules on the hands of a teenage girl. Shaughnessy, CN; Lucky, AW. Pediatric Dermatology. 2019; 36:E81-E82.

Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America. Feinstein, JA; Jambal, P; Peoples, K; Lucky, AW; Khuu, P; Tang, JY; Lara-Corrales, I; Pope, E; Wiss, K; Hook, KP; et al. JAMA Dermatology. 2019; 155:196-203.

Epidermolysis bullosa simplex-generalized severe type due to keratin 5 p.Glu477Lys mutation: Genotype-phenotype correlation and in silico modeling analysis. Lalor, L; Titeux, M; Palisson, F; Fuentes, I; Yubero, MJ; Tasanen, K; Huilaja, L; Has, C; Tadini, G; Haggstrom, AN; et al. Pediatric Dermatology. 2019; 36:132-138.

Clinical algorithm to manage anemia in epidermolysis bullosa. Simpson, B; Tarango, C; Lucky, AW. Pediatric Dermatology. 2018; 35:e319-e320.

Pediatric Ophthalmoplegia and Ptosis in Epidermolysis Bullosa Simplex Associated With Muscular Dystrophy. Al-Thawabieh, W; Lucky, AW; Wong, B; Motley, WW. Journal of Pediatric Ophthalmology and Strabismus. 2018; 55:e26-e29.

Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB). Bruckner, AL; Fairclough, DL; Feinstein, JA; Lara-Corrales, I; Lucky, AW; Tolar, J; Pope, E. British Journal of Dermatology. 2018; 178:1128-1134.

A comprehensive next-generation sequencing assay for the diagnosis of epidermolysis bullosa. Lucky, AW; Dagaonkar, N; Lammers, K; Husami, A; Kissell, D; Zhang, K. Pediatric Dermatology. 2018; 35:188-197.

Ventricular dysfunction and aortic dilation in patients with recessive dystrophic epidermolysis bullosa. Ryan, TD; Lucky, AW; King, EC; Huang, G; Towbin, JA; Jefferies, JL. British Journal of Dermatology. 2016; 174:671-673.

Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. Adams, DM; III, TC C; Hammill, AM; Vinks, AA; Patel, MN; Chaudry, G; Wentzel, MS; Mobberley-Schuman, PS; Campbell, LM; Brookbank, C; et al. Pediatrics. 2016; 137:e20153257-e20153257.